According to the latest publication by the Society for Assisted Reproductive Technology (SART), RMANJ once again is leading the way in the number of IVF cycles resulting in live births. Compared to U.S. averages, RMANJ’s success rates are consistently higher than the national average. More specifically, *72.4% of new patients under the age of 35 that were seen in 2014 were able to conceive a child successfully.
While these numbers are remarkable, there are other statistics that should be pointed out in order to understand the significance of this trend held by RMANJ for more than a decade. First, these exceptional
A new reproductive technology used with single-embryo transfer (SET) is helping fertility specialists achieve more pregnancies with fewer miscarriages. Reproductive Medicine Associates (RMA) of Philadelphia is offering SET with comprehensive chromosome screening (CCS), especially for patients ages 35 or older, or with multiple unsuccessful in vitro fertilization (IVF) cycles or miscarriages. The new test helps confirm that the embryo selected for transfer has the correct number of chromosomes and so is more likely to result in a sustained pregnancy.
Why use SET-CCS?
When clinically indicated, SET-CCS can reduce pregnancy losses since about 60% of early miscarriages are due to chromosomal abnormalities in the embryo.